Masco Group now a major stakeholder of Swedish company, KeyPlants AB

Summary: Masco Group buys a majority stake in KeyPlants AB, bolstering the company's flexible facilities and engineering technology solutions for life sciences customers.

Fremont, CA ;The healthcare industry has been hit by the digital disruption wave. While the scope and speed of change this will bring to the industry are still being debated, there is no doubt that transformation is already underway. Several disruptive forces in the healthcare sector have been pushing this barrier and changing the way patients are catered to. The Masco Group has acquired a major share in KeyPlants AB, a Swedish company. Masco's position in engineering technology for bio sciences will be strengthened as a result of this move.

By combining Masco Group's leadership in clean utilities and process technologies with KeyPlants' knowledge and innovative energy in prefabricated, modular facility solutions, this cooperation will boost Masco Group. It will provide a global customer base of biopharmaceutical manufacturers and CDMOs focused on biologics, pharma, and advanced therapy medicinal products (ATMPs), such as cell and gene therapies, with stronger value propositions for global supply chain challenges such as flexibility, reliability, and fast-track manufacturing timelines.

KeyPlants is a leading international industry partner for process-integrated modular prefabricated facility solutions that are both standardized and customizable. The company, based in Stockholm, has a completely integrated supply chain with more than 45 years of project engineering, manufacture, and delivery experience, and has delivered over 3,500 high-specification modules to at least 30 nations.

“We are extremely happy to partner with KeyPlants, as it will expand our capabilities, service and product offerings, and evolve our manufacturing capacity,” says Luca Borella, CEO of Masco Group. “We look forward to working with them to further accelerate the global adoption of their innovative fast-track facility solutions, which are an essential aspect in the life science industry.The companies share similar values, notably the commitment to teamwork, sustainability and customer care. Innovation is also an important synergetic element.”